Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
USA: A recent study linking preconception alcohol use by fathers to birth defects has been published in the Journal of Clinical Investigation.
Read Full NewsThe largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.
Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.
1.
Including Bereavement in the Care Continuum.
2.
Adding cell-based vaccine to liver cancer therapy can slow cancer progression
3.
NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.
4.
Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.
5.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
1.
IGF2BP1 in Blood Disorders: Therapeutic Potential and Comprehensive Functional Insights
2.
Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation
3.
The Unseen Danger of Anal Cancer: How to Protect Yourself
4.
Contemporary Frameworks in Oncology Across Clinical Settings
5.
The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge